Welcure Drugs & Pharmaceuticals Ltd. reported unaudited standalone earnings results for the third quarter and nine months ended December 31, 2015. For the quarter, the company reported loss from operations before other income, finance costs and exceptional items was INR 0.146 million against INR 0.029 million a year ago. Loss from ordinary activities before tax was INR 0.134 million against INR 0.021 million a year ago. Net loss for the period was INR 0.134 million against INR 0.021 million for the same period a year ago.

For the nine months, the company reported total income from operations of INR 0.632 million. Profit from operations before other income, finance costs and exceptional items was INR 0.067 million against loss of INR 0.410 million a year ago. Profit from ordinary activities before tax was INR 0.082 million against loss of INR 0.017 million a year ago. Net profit for the period was INR 0.082 million against INR 0.017 million for the same period a year ago.